Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Nature Communications
|
September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B Gilbert, David C Montefiori, Adrian McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine
Youyi Fong, Yunda Huang, Ying Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2024
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Youyi Fong, Lauren Dang, Bo Zhang, et al.
The Lancet. HIV
|
May 11, 2026
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial
Sharana Mahomed, Carmen A Paez, Yunda Huang, et al.
Vaccine
|
February 16, 2026
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Fei Heng, Craig A Magaret, Nadine G Rouphael, et al.
Science Translational Medicine
|
April 19, 2023
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
David Benkeser, David C Montefiori, Adrian B McDermott, et al.
Nature Communications
|
January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Viruses
|
October 28, 2023
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
Ying Huang, Nima S Hejazi, Bryan Blette, et al.
Nature Communications
|
November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Lindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Nature Communications
|
September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B Gilbert, David C Montefiori, Adrian McDermott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine
Youyi Fong, Yunda Huang, Ying Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2024
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Youyi Fong, Lauren Dang, Bo Zhang, et al.
The Lancet. HIV
|
May 11, 2026
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial
Sharana Mahomed, Carmen A Paez, Yunda Huang, et al.
Vaccine
|
February 16, 2026
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Fei Heng, Craig A Magaret, Nadine G Rouphael, et al.
Science Translational Medicine
|
April 19, 2023
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
David Benkeser, David C Montefiori, Adrian B McDermott, et al.
Nature Communications
|
January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Viruses
|
October 28, 2023
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
Ying Huang, Nima S Hejazi, Bryan Blette, et al.
Nature Communications
|
November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Lindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Page
of 8